These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immunosuppressive effect of brequinar on rat cardiac allograft survival in combination with leflunomide or FK 506. D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P Transplant Proc; 1996 Apr; 28(2):950-1. PubMed ID: 8623476 [No Abstract] [Full Text] [Related]
3. Efficacy of leflunomide in combination with current immunosuppressive agents in rat cardiac allotransplantation. Candinas D; Achilleos O; Lee SJ; Dalgic A; Mayer AD; Buckels JA; McMaster P; D'Silva M Transplant Proc; 1994 Dec; 26(6):3251-2. PubMed ID: 7527959 [No Abstract] [Full Text] [Related]
4. Effect of brequinar sodium on accelerated cardiac allograft rejection in presensitized recipients. Nozaki S; Ito T; Kamiike W; Uchikoshi F; Yamamoto S; Nakata S; Shirakura R; Miyata M; Matsuda H; Stepkowski SM Transplant Proc; 1994 Aug; 26(4):2333-5. PubMed ID: 7520633 [No Abstract] [Full Text] [Related]
5. Immunosuppressive effects of leflunomide in a cardiac allograft model. Williams JW; Xiao F; Foster PF; Chong A; Sharma S; Bartlett R; Sankary HN Transplant Proc; 1993 Feb; 25(1 Pt 1):745-6. PubMed ID: 8438465 [No Abstract] [Full Text] [Related]
7. Difference in immunosuppressive effects of antibodies to ICAM-1 and LFA-1 between hepatic and cardiac allografts. Harihara Y; Sugawara Y; Inoue K; Kubota K; Bandai Y; Makuuchi M; Miyasaka M Transplant Proc; 1996 Jun; 28(3):1368-9. PubMed ID: 8658698 [No Abstract] [Full Text] [Related]
8. Cardiac graft rejection in hypersensitized recipients: prevention of antibody response and graft rejection using brequinar sodium. Yasunaga C; Cramer DV; Chapman FA; Wang HK; Barnett M; Wu GD; Makowka L Transplant Proc; 1993 Jun; 25(3 Suppl 2):65-6. PubMed ID: 8516948 [No Abstract] [Full Text] [Related]
9. Is the malononitrilamide FK778 better for the prevention of acute or chronic rejection? Deuse T; Schrepfer S; Pelletier MP; Fischbein MP; Robbins RC; Reichenspurner H Transplant Proc; 2007 Mar; 39(2):569-72. PubMed ID: 17362784 [TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive effect of RS-61443 on rat cardiac allograft survival in combination with leflunomide or FK 506. D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P Transplant Proc; 1996 Apr; 28(2):930-1. PubMed ID: 8623467 [No Abstract] [Full Text] [Related]
11. FK 506 prolongs survival of liver but not heart mouse-to-rat vascularized xenografts. Pan F; Valdivia LA; Tsugita M; Celli S; Haeuchi K; Demetris AJ; Avci G; Fung JJ Transplant Proc; 1994 Jun; 26(3):1211. PubMed ID: 7518113 [No Abstract] [Full Text] [Related]
12. Graft coronary arteriosclerosis in rat heart transplant model with FK 506 short-term administration. Izutani H; Miyagawa S; Matsumiya G; Nakata S; Shimazaki Y; Matsuda H; Shirakura R Transplant Proc; 1995 Feb; 27(1):579-81. PubMed ID: 7533425 [No Abstract] [Full Text] [Related]
13. Monoclonal antibodies against LFA-1 and VLA-4 inhibit graft vasculitis in rat cardiac allografts. Paul LC; Davidoff A; Paul DW; Benediktsson H; Issekutz TB Transplant Proc; 1993 Feb; 25(1 Pt 1):813-4. PubMed ID: 8438494 [No Abstract] [Full Text] [Related]
14. Role of ICAM-1 and LFA-1 in cardiac allograft rejection of the rat. Komori A; Nagata M; Ochiai T; Nakajima K; Hori S; Asano T; Isono K; Tamatani T; Miyasaka M Transplant Proc; 1993 Feb; 25(1 Pt 1):831-2. PubMed ID: 8094916 [No Abstract] [Full Text] [Related]
15. Intrathymic injection of alloantigen may lead to hyperacute rejection and prolonged graft survival of heart allografts in the rat. de Bruin RW; van Rossum TJ; Scheringa M; Bonthuis F; IJzermans JN; Marquet RL Transplantation; 1995 Nov; 60(9):1061-3. PubMed ID: 7491686 [No Abstract] [Full Text] [Related]
16. Interaction between rapamycin and pretransplant blood transfusions in rat heterotopic heart transplantation. Tucker MJ; Duplan J; Li X; Garcia B; Wijsman J; Stiller C; McKenzie FN Transplant Proc; 1993 Feb; 25(1 Pt 1):725-6. PubMed ID: 8438458 [No Abstract] [Full Text] [Related]
17. Is donor-specific blood transfusion effective for strong minor histocompatibility antigen barriers? Hara MH; Suzuki H; Shibata K; Tanigawa M; Sekiya R; Matsuzaki Y; Onitsuka T; Koga Y; Yamashita A; Miyamoto M; Suzuki S; Amemiya H; Kimura H Transplant Proc; 1996 Jun; 28(3):1268-9. PubMed ID: 8658654 [No Abstract] [Full Text] [Related]
18. Involvement of clonal deletion in immunotolerance induction: tests of Tacrolimus administration in rat renal transplantation. Hayakawa K; Hata M; Yanaihara H; Ohashi M; Ishikawa H; Tazaki H Transplant Proc; 1994 Aug; 26(4):1863-5. PubMed ID: 7520608 [No Abstract] [Full Text] [Related]
19. Gene expression profiling of acute rejection and mixed lymphocyte reaction with tacrolimus immunosuppression. Erickson L; Crews G; Pan F; Kobayashi M; Jiang H Transplant Proc; 2002 Aug; 34(5):1385-6. PubMed ID: 12176407 [No Abstract] [Full Text] [Related]
20. Late xenograft rejection: comparison between liver and heart xenografts under low-dose tacrolimus. MollevĂ DG; Morell GinestĂ M; Ribas Y; Mestre M; Vidal A; Serano T; Figueras J; Jaurrieta J Transplant Proc; 2002 Feb; 34(1):111-2. PubMed ID: 11959212 [No Abstract] [Full Text] [Related] [Next] [New Search]